GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultimovacs ASA (STU:7UM) » Definitions » Dividend-Payout-to-FFO

Ultimovacs ASA (STU:7UM) Dividend-Payout-to-FFO


View and export this data going back to 2021. Start your Free Trial

What is Ultimovacs ASA Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Ultimovacs ASA (STU:7UM) Business Description

Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.